JVDI Advertisement
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duhamel, G.
Right arrow Articles by Walter, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duhamel, G.
Right arrow Articles by Walter, D
Journal of Veterinary Diagnostic Investigation, Vol 10, Issue 4, 350-356
Copyright © 1998 by American Association of Veterinary Laboratory Diagnosticians


Articles

In vitro activity of four antimicrobial agents against North American isolates of porcine Serpulina pilosicoli

GE Duhamel, JM Kinyon, MR Mathiesen, DP Murphy, and D Walter

Department of Veterinary & Biomedical Sciences, University of Nebraska, Lincoln 68583-0905, USA.

Porcine colonic spirochetosis is a nonfatal diarrheal disease that affects pigs during the growing and finishing stages of production. The disease is caused by Serpulina pilosicoli, a newly recognized species of pathogenic intestinal spirochete. Antimicrobial therapy aimed at reducing the infection may be helpful in controlling spirochetal diarrhea. In this study, the in vitro antimicrobial susceptibilities of the reference isolate S. pilosicoli P43/6/78 from the United Kingdom and 19 field isolates obtained from pigs in Canada (n = 5) and the United States (n = 14) were determined against the antimicrobial agents carbadox, gentamicin, lincomycin, and tiamulin, all of which are commonly used for control of the related pathogenic intestinal spirochete S. hyodysenteriae. Additionally, the susceptibility or resistance of each isolate against each antimicrobial agent was estimated on the basis of available data on the in vitro antimicrobial susceptibility breakpoints of S. hyodysenteriae. Each isolate was identified on the basis of phenotypic and genotypic markers, and the minimum inhibitory concentration of each antimicrobial agent was determined by the agar-dilution method. All the isolates were susceptible to carbadox and tiamulin. The percentages of isolates susceptible, intermediate, and resistant to lincomycin were 42.1%, 42.1%, and 15.8%, respectively. Slightly less than half of the isolates (47.4%) were susceptible to gentamicin, and the remainder (52.6%) were resistant. Implementation of rational control measures to reduce infection by S. pilosicoli should improve overall health and productivity in swine herds.


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
C. J. Brooke, D. J. Hampson, and T. V. Riley
In Vitro Antimicrobial Susceptibility of Brachyspira pilosicoli Isolates from Humans
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2354 - 2357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association of Veterinary Laboratory Diagnosticians, Inc.